BIONEERCORPORATION Logo

BIONEERCORPORATION

Provides molecular biology tools & diagnostic kits for research and clinical applications.

064550 | KO

Overview

Corporate Details

ISIN(s):
KR7064550007
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노2로 71 (주)바이오니아 글로벌센터, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1992, Bioneer Corporation is a biotechnology company specializing in molecular biology products and technologies. The company develops, manufactures, and supplies a comprehensive portfolio for the life sciences and molecular diagnostics (MDx) markets. Its core offerings include proprietary MDx systems and diagnostic kits for various infectious diseases, such as SARS-CoV-2, HIV, HBV, and HCV. Bioneer also provides a wide array of molecular biology reagents, gene synthesis services, PCR systems, and recombinant proteins. A key area of innovation is in laboratory instrumentation, including its patented AccuLoader™ precision device for automated sample handling. The company serves research, clinical, and industrial customers, providing a platform for disease prevention, diagnosis, and treatment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-07-31 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-06-18 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 6.4 KB
2025-06-12 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-06-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 123.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-30 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-04-30 00:00
Regulatory Filings
소속부변경
Korean 3.6 KB
2025-04-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 134.0 KB
2025-03-31 00:00
AGM Information
정기주주총회결과
Korean 21.3 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 26.2 KB
2025-03-21 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 644.0 KB
2025-03-20 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 123.8 KB
2025-03-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB

Automate Your Workflow. Get a real-time feed of all BIONEERCORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIONEERCORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIONEERCORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Protagonist Therapeutics, Inc Logo
Develops peptide therapeutics for blood disorders and inflammatory or immunomodulatory diseases.
United States of America
PTGX
Protalix BioTherapeutics, Inc. Logo
Develops plant-cell-based protein therapies for rare diseases like Gaucher and Fabry.
United States of America
PLX
PROTIA INC. Logo
Develops IVD kits and instruments for allergy, POCT, infectious & autoimmune diseases.
South Korea
303360
PSYENCE BIOMEDICAL LTD. Logo
Developing natural psilocybin therapies for anxiety and depression in palliative care.
United States of America
PBM
PTC THERAPEUTICS, INC. Logo
Develops and commercializes pioneering medicines for patients with rare diseases.
United States of America
PTCT
Pulmatrix, Inc. Logo
Develops inhaled therapies for respiratory and CNS disorders using its iSPERSE™ technology.
United States of America
PULM
PUMA BIOTECHNOLOGY, INC. Logo
Develops and commercializes innovative cancer therapeutics, with an approved drug and a clinical pipeline.
United States of America
PBYI
Pure Biologics S.A. Logo
Develops novel antibody & aptamer drugs for immuno-oncology and autoimmune diseases.
Poland
PUR
PureTech Health plc Logo
A clinical-stage biotherapeutics firm developing new medicines for devastating diseases.
United States of America
PRTC
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel
PPBT

Talk to a Data Expert

Have a question? We'll get back to you promptly.